发明名称 |
PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS |
摘要 |
This invention describes novel pyrazole compounds of formula II:wherein Ring C is selected from a phenyl, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, or 1, 2, 4-triazinyl ring, and R<2>, R<2>, R<x>, and R<y> are as described in the specification. Ring C has an ortho substituent and is optionally substituted in the non-ortho positions. R<2> and R<2> are optionally taken together with their intervening atoms to form a fused ring system, such as an indazole ring; and R<x> and R<y> are optionally taken together with their intervening atoms to form a fused ring system, such as a quinazoline ring. The compounds are useful as protein kinase inhibitors, especially as inhibitors of GSK-3, for treating diseases such as diabetes and Alzheimer's disease.
|
申请公布号 |
WO0222607(A1) |
申请公布日期 |
2002.03.21 |
申请号 |
WO2001US28940 |
申请日期 |
2001.09.14 |
申请人 |
VERTEX PHARMACEUTICALS INCORPORATED;DAVIES, ROBERT;BEBBINGTON, DAVID;KNEGTEL, RONALD;WANNAMAKER, MARION;LI, PAN;FORESTER, CORNELIA;PIERCE, ALBERT;KAY, DAVID |
发明人 |
DAVIES, ROBERT;BEBBINGTON, DAVID;KNEGTEL, RONALD;WANNAMAKER, MARION;LI, PAN;FORESTER, CORNELIA;PIERCE, ALBERT;KAY, DAVID |
分类号 |
C07D403/12;A61K31/415;A61K31/437;A61K31/4709;A61K31/4725;A61K31/501;A61K31/5025;A61K31/506;A61K31/517;A61K31/519;A61K31/52;A61K31/53;A61K31/5377;A61K31/541;A61K31/55;A61K45/00;A61P1/16;A61P3/08;A61P3/10;A61P3/14;A61P5/00;A61P9/00;A61P9/10;A61P11/06;A61P17/06;A61P19/00;A61P19/02;A61P19/10;A61P25/18;A61P25/28;A61P29/00;A61P31/12;A61P35/00;A61P35/02;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D239/26;C07D239/36;C07D239/70;C07D239/88;C07D401/12;C07D401/14;C07D403/14;C07D405/14;C07D407/14;C07D409/14;C07D413/14;C07D417/14;C07D471/04;C07D473/16;C07D475/10;C07D487/04;C07D491/04;C07D491/044;C07D491/048;C07D491/052;C07D491/107;C07D491/113;C07D491/20;C07D493/04;C07D495/04;C07D498/04;C07D513/04;C07D521/00;(IPC1-7):C07D403/12 |
主分类号 |
C07D403/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|